Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ascentage Pharma Announces Clinical Trial Application for Olverembatinib (HQP1351) Approved in Canada 2022-07-22 07:59
ImmVira's intravenous administered oHSV MVR-T3011 IV demonstrated promising clinical biological activities 2022-07-21 08:00
Daewoong Pharmaceutical Gets First Korean US FDA Fast-Track for New Idiopathic Pulmonary Fibrosis Drug 2022-07-20 21:00
Ascentage Pharma and Innovent Announce the China NMPA Accepted and Granted Priority Review Designation to a New Drug Application for Olverembatinib for the Treatment of Drug-Resistant CML 2022-07-20 00:15
Gracell Biotechnologies Appoints Veteran BioPharma Executive Dr. Samuel Zhang as Chief Business Officer 2022-07-19 20:00
OliPass Moves Forward to Second Stage of Phase 2a Trial for Pain Killer OLP-1002 2022-07-18 20:00
Samsung Biologics to purchase land for its second Bio Campus 2022-07-18 19:00
Everest Medicines Announces European Commission Grants Approval of Kinpeygo® for Adults with Primary IgA Nephropathy to our Partner Calliditas Therapeutics 2022-07-18 08:00
China CDE Grants Breakthrough Therapy Designation (BTD) to Neurophth's NR082 in LHON 2022-07-15 21:00
Bridge Biotherapeutics to Present Interim Clinical Data from Ongoing Phase 1 Study of BBT-176 at the World Conference of Lung Cancer 2022-07-13 06:30
Flat Medical Enters the Vascular Access Medtech Domain with its Newly Acquired MDR Certification and New Medical Advisor 2022-07-12 21:08
WuXi Vaccines Received First GMP Certificate of QC Potency Lab from Ireland Health Products Regulatory Authority 2022-07-12 16:00
iNtRON Confirms Efficacy of CDL200 Against CDI Clinical Isolates 2022-07-12 10:06
'Sustainable CDMO' Samsung Biologics releases 2022 ESG Report 2022-07-11 19:00
NEW EARLY BREAST CANCER DRUG TO REDUCE RISK OF RECURRENCE OR DEATH NOW AVAILABLE IN THE PHILIPPINES 2022-07-08 09:28
SunHo Announces First Patient Dosed in Phase 1/2 Clinical Trial of Two First-in-class Immunocytokines: IAP0971 and IAE0972 2022-07-07 20:00
Alterity Therapeutics Doses First Patient in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy 2022-07-06 23:00
I-Mab to Host 2022 R&D Day 2022-07-06 20:00
US FDA AWARDS RARE PEDIATRIC DISEASE DESIGNATION (RPDD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER 2022-07-06 19:00
Inmagene and HUTCHMED Announce First Participants in Global Phase I Trial of IMG-007 2022-07-06 12:00
1 54 55 56 57 58 147